• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APPLIED BIOCODE, INC. BIOCODE® GASTROINTESTINAL PATHOGEN PANEL (GPP)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APPLIED BIOCODE, INC. BIOCODE® GASTROINTESTINAL PATHOGEN PANEL (GPP) Back to Search Results
Model Number GPP FINISHED KIT
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/18/2022
Event Type  malfunction  
Manufacturer Narrative
The 3rd party study evaluated the applied biocode gpp with the focus on the four most common bacterial targets and the virus and parasite targets.The study compared retrospective results from gi pathogen detection from applied biocode gpp to testing by bd max enteric bacterial panel.Discordant results were found specific to campylobacter.Upon internal testing by applied biocode, the reported issues with campylobacter was confirmed and isolated to one specific lot, aa-06002.Additional internal testing was conducted by abc with another lot which demonstrated 100% concordance with that lot and confirmed the reported issue was isolated to lot aa-06002.These study results were presented at the american society for microbiology (asm) poster #3866.
 
Event Description
The initial reported information reported discordant results with campylobacter during a retrospective comparison study with bd and culture.The customer was requesting applied biocode (abc) to provide historical data to support their performance study.Abc requested that the customer provide samples for internal testing.Abc's preliminary testing results showed a very strong positive for campylobacter lot aa-06002, which were not detected (false negarive).Subsequent testing internal testing by abc with additional campylobacter lot was performed and concluded the false negative outcomes were specific to lot aa-06002.The comparison study which included more than 300 samples which were tested of abc's gastrointestinal pathogen panel (gpp) good concordance for most targets.The retrospective review of samples tested by in-use method and by abc post reagent lot change demostrated 100% concordance.Reference: american society of microbiology (asm) poster #3866.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOCODE® GASTROINTESTINAL PATHOGEN PANEL (GPP)
Type of Device
GASTROINTESTINAL PATHOGEN PANEL
Manufacturer (Section D)
APPLIED BIOCODE, INC.
12130 mora drive
unit 2
santa fe springs CA 90670
Manufacturer Contact
mary carvajal
12130 mora drive
unit 2
santa fe springs, CA 90670
7143430022
MDR Report Key14825373
MDR Text Key303084498
Report Number3007799234-2022-00003
Device Sequence Number1
Product Code PCH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K190585
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation 505
Type of Report Initial
Report Date 06/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/27/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberGPP FINISHED KIT
Device Lot NumberAA-06002
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/27/2022
Date Manufacturer Received01/18/2022
Was Device Evaluated by Manufacturer? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-